Analyses of circulating tumor cell (CTC) dynamics and treatment response in prostate cancer using the CTC-chip microfluidic device

被引:0
|
作者
Lee, R. J. [1 ]
Stott, S. L. [1 ]
Nagrath, S. [1 ]
Ulkus, L. E. [1 ]
Dahl, D. M. [1 ]
Smith, M. R. [1 ]
Toner, M. [1 ]
Maheswaran, S. [1 ]
Haber, D. A. [1 ]
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5149
引用
收藏
页数:1
相关论文
共 50 条
  • [21] On passing a non-Newtonian circulating tumor cell (CTC) through a deformation-based microfluidic chip
    Xiaolong Zhang
    Mohammad Abul Hashem
    Xiaolin Chen
    Hua Tan
    Theoretical and Computational Fluid Dynamics, 2018, 32 : 753 - 764
  • [22] Separation of CTC using microfluidic chip from patients with colorectal cancer
    Wakizaka, Yoshikazu
    Takemura, Yukitoshi
    Ohta, Ryo
    Yamada, Takeshi
    Yoshida, Hiroshi
    CANCER SCIENCE, 2021, 112 : 879 - 879
  • [23] Utility of circulating tumor cell (CTC) in advanced gastric cancer
    Lee, Won Suk
    Kim, Jeong Min
    Kwon, Woo Sun
    Lim, So Jung
    Kim, Tae Soo
    Kim, Ga Yun
    Choi, Sung Ho
    Jeon, Byung Hee
    Jung, Min Kyu
    Ahn, Joong Bae
    Chung, Hyun Cheol
    Rha, Sun Young
    CANCER RESEARCH, 2015, 75
  • [24] Blood biopsy on a microfluidic CTC-chip for non-invasive detection, monitoring and genotyping of tumors in lung cancer
    Nagrath, Sunitha
    Maheswaran, Shyamala
    Sequist, Lecia
    Ulkus, Lindsey
    Brannigan, Brian
    Collura, Chey
    Iafrate, John
    Digumarthy, Subba
    Muzikansky, Alona
    Settleman, Jeffrey
    Lynch, Thomas
    Haber, Daniel
    Toner, Mehmet
    CANCER RESEARCH, 2009, 69
  • [25] Molecular characterization of circulating tumor cells (CTC) and CTC subpopulations in progressive metastatic castration resistant prostate cancer (mCRPC).
    Dittamore, Ryan
    Louw, Jessica
    Krupa, Rachel
    Anand, Aseem
    Danila, Daniel Costin
    Arslan, Zaina
    Bales, Natalee
    Marrinucci, Dena
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [26] CIRCULATING TUMOR CELLS (CTC) AS BIOMARKERS IN RECURRENT AND CASTRATION RESISTANT PROSTATE CANCER
    Boegemann, M.
    ANTICANCER RESEARCH, 2014, 34 (11) : 6802 - 6802
  • [27] Biological significance of novel populations of prostate cancer circulating tumor cells (CTC).
    Davis, Ian D.
    Pezaro, Carmel Jo
    Wardan, Hady
    Sluka, Pavel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [28] Molecular assessment of cell surface targets using integrated circulating tumor cell (CTC) RNAseq and single CTC phenotyping
    Sperger, Jamie M.
    Sharifi, Marina N.
    Kaufmann, Katherine R.
    Bootsma, Matthew L.
    Reese, Shannon R.
    Carreno, Viridiana
    Chang, Alex H.
    Nunamaker, Luke A.
    Nunamaker, A.
    Linebarger, Charlotte
    Taylor, Amy K.
    Tippins, Katherine E.
    Helzer, Kyle T.
    Zhao, Shuang G.
    Lang, Joshua M.
    CLINICAL CANCER RESEARCH, 2024, 30 (21)
  • [29] Microfluidic detection of circulating tumor cells (CTC) using size filtration based capture
    Lee, Sung-Woo
    Jung, Hyo-Il
    Kang, Ji-Yoon
    6TH IEEE INTERNATIONAL CONFERENCE ON NANO/MOLECULAR MEDICINE AND ENGINEERING (IEEE-NANOMED 2012), 2012,
  • [30] Impact of biopsy of metastases on circulating tumor cell (CTC) counts in castrate resistant prostate cancer (CRPC)
    Kohli, M.
    Tan, W.
    Eiken, P.
    McMenomy, B.
    Atwell, T.
    Carlson, R.
    Campion, M.
    Wang, L.
    Costello, B.
    Pitot, H.
    Quevedo, F.
    Ho, T.
    Bryce, A.
    Qin, R.
    Paz-Fumagalli, R.
    Moynihan, T.
    Dronca, R.
    Liu, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S502 - S502